Brief: PYC Therapeutics Says Co On-Track For Investigational New Drug Application In Mid-2022
28/07/2021 12:11
July 28 (Reuters) - PYC Therapeutics Ltd PYC.AX :
* PYC THERAPEUTICS HIGHLIGHTS ADVANCEMENT OF OCULAR AND CNS
DEVELOPMENT PROGRAMS AND CONTINUED U.S. EXPANSION IN SECOND
QUARTER 2021 UPDATE
* PYC THERAPEUTICS LTD - ON-TRACK FOR INVESTIGATIONAL NEW
DRUG
APPLICATION IN MID-2022
Source text for Eikon: ID:nPn9Lks54a
Further company coverage: PYC.AX
Recent news on PYC Therapeutics
See all newsAustralia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million
Brief: PYC Therapeutics Seeks Trading Halt
Brief: PYC Therapeutics Says Rohan Hockings Re-Appointed As Managing Director